Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Current guidelines for adult GH replacement.

Literature DB >> 15711916

Current guidelines for adult GH replacement.

Mauro Doga¹, Stefania Bonadonna, Monica Gola, Sebastiano Bruno Solerte, Giovanni Amato, Carlo Carella, Andrea Giustina.

Abstract

Mesh：

Substances：

Year: 2005 PMID： 15711916 DOI： 10.1007/s11154-005-5226-y

Source DB: PubMed Journal: Rev Endocr Metab Disord ISSN： 1389-9155 Impact factor: 6.514

× No keyword cloud information.

38 in total

Review 1. Design and interpretation of studies of the risk of cancer and other long-term morbidity and mortality after growth hormone treatment.

Authors: A J Swerdlow
Journal: Growth Horm IGF Res Date: 2000-12 Impact factor: 2.372

Review 2. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human.

Authors: A Giustina; J D Veldhuis
Journal: Endocr Rev Date: 1998-12 Impact factor: 19.871

Review 3. Safety issues in children and adolescents during growth hormone therapy--a review.

Authors: P E Clayton; C T Cowell
Journal: Growth Horm IGF Res Date: 2000-12 Impact factor: 2.372

4. Serum profiles and short-term metabolic effect of pituitary and authentic biosynthetic human growth hormone in man. A double-blind cross-over study.

Authors: J O Jørgensen; A Flyvbjerg; J Dinesen; H Lund; K G Alberti; H Orskov; J S Christiansen
Journal: Acta Endocrinol (Copenh) Date: 1987-11

5. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.

Authors: M Thorén; A Hilding; R C Baxter; M Degerblad; I L Wivall-Helleryd; K Hall
Journal: J Clin Endocrinol Metab Date: 1997-01 Impact factor: 5.958

6. Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency.

Authors: B M Biller; G Sesmilo; H B Baum; D Hayden; D Schoenfeld; A Klibanski
Journal: J Clin Endocrinol Metab Date: 2000-03 Impact factor: 5.958

7. The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition.

Authors: A Binnerts; G R Swart; J H Wilson; N Hoogerbrugge; H A Pols; J C Birkenhager; S W Lamberts
Journal: Clin Endocrinol (Oxf) Date: 1992-07 Impact factor: 3.478

8. Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GH in a placebo-controlled 21-month trial.

Authors: P Burman; J E Broman; J Hetta; I Wiklund; E M Erfurth; E Hagg; F A Karlsson
Journal: J Clin Endocrinol Metab Date: 1995-12 Impact factor: 5.958

Current guidelines for adult GH replacement.

Review 1. Design and interpretation of studies of the risk of cancer and other long-term morbidity and mortality after growth hormone treatment.

Review 2. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human.

Review 3. Safety issues in children and adolescents during growth hormone therapy--a review.

4. Serum profiles and short-term metabolic effect of pituitary and authentic biosynthetic human growth hormone in man. A double-blind cross-over study.

5. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.

6. Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency.

7. The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition.

8. Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GH in a placebo-controlled 21-month trial.

9. Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers.

10. Premature mortality due to cardiovascular disease in hypopituitarism.

Review 1. Update in new anabolic therapies for osteoporosis.

Review 2. Growth hormone deficiency in the adult.

Review 3. The metabolic effects of growth hormone in adipose tissue.

4. Reversible brain lesion following growth hormone replacement therapy in an adolescent.

Review 5. Glucocorticoids and the regulation of growth hormone secretion.

Review 6. Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults.

7. Low prevalence of growth hormone deficiency in Turkish patients with Hashimoto's thyroiditis.

8. Treatment of Cushing disease: overview and recent findings.

Review 9. MANAGEMENT OF ENDOCRINE DISEASE: Novel anabolic treatments for osteoporosis.

Review 10. Growth hormone, insulin-like growth factors, and the skeleton.